Post Marketing Surveillance of Roflumilast in Korea
NCT02068456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1837
Last updated 2017-06-22
Summary
The purpose of this study is to evaluate the safety and efficacy of roflumilast in the real-use conditions with its registered indications.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca AstraZeneca · AstraZeneca
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-18
- Primary Completion
- 2017-04-26
- Completion
- 2017-04-26
Countries
- South Korea
Study Locations
More Related Trials
-
Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)
NCT00246922 ·Status: COMPLETED ·Phase: PHASE3
-
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
NCT00076076 ·Status: COMPLETED ·Phase: PHASE3
-
Roflumilast Plus Montelukast in Adults With Severe Asthma
NCT01765192 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Patients With Asthma
NCT00215410 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma
NCT01365533 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled Formoterol
NCT00940329 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Montelukast on Smokers With Asthma
NCT00712335 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
NCT01085474 ·Status: COMPLETED
-
Study to Evaluate GSK2190915 in Subjects With Mild Asthma
NCT00812773 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
NCT01436071 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma Control in Elderly Patients With Montelukast
NCT01147510 ·Status: COMPLETED ·Phase: PHASE4
-
Study in Patients With Asthma
NCT00215397 ·Status: COMPLETED ·Phase: PHASE2
-
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413 ·Status: RECRUITING
-
Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma
NCT00380354 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Patients With Asthma
NCT00215371 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Pharmacokinetics of QAW039
NCT01253603 ·Status: COMPLETED ·Phase: PHASE2
-
The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
NCT01370577 ·Status: COMPLETED
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
NCT04108377 ·Status: TERMINATED ·Phase: PHASE1
-
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
NCT01591044 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
NCT00150397 ·Status: COMPLETED ·Phase: PHASE2
-
PF-04191834 Single Dose Bronchodilatory Study In Asthma.
NCT00723021 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Patients With Asthma
NCT00215358 ·Status: COMPLETED ·Phase: PHASE2
-
Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma
NCT00354666 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
NCT00843193 ·Status: COMPLETED ·Phase: PHASE2